STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
33 hedge funds and large institutions have $17.6M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-8
Holders Change %
-19.51%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
8
Reduced
11
Closed
17
Calls
$262K
Puts
$2K
Net Calls
+$260K
Net Calls Change
-$4.98M
Top Buyers
Top Sellers
| 1 |
CC
Commodore Capital
New York
|
$0 |
| 2 |
SC
Samlyn Capital
New York
|
$0 |
| 3 |
TGA
TPG GP A
Fort Worth,
Texas
|
$0 |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
$0 |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$0 |
